多克索菲林与帕洛克斯上腹腔动心:一个病例报告
Dandan Yu1, Min Liu1, Wei Tang1
1Department of Neurology, Dalian University Affiliated Xinhua Hospital, Dalian, Liaoning, China.
德克索菲林输液很少会导致心跳上心跳动 (PSVT),这是一种心律问题. 这种不良药物反应虽然不常见,但在患有心的患者中需要临床关注和进一步调查.
科学领域:
- 药理学 药理学是指药理学的学科.
- 心脏病学 心脏病学
- 临床病例报告 临床病例报告
背景情况:
- 多克索菲林是一种用于呼吸道疾病的支气管扩展剂.
- 药物不良反应需要仔细监测和报告.
研究的目的:
- 在静脉注射多克索菲林后报告患有帕洛西斯马上心室高心率 (PSVT) 的病例.
- 为了突出多克索菲林的潜在罕见不良影响.
主要方法:
- 一个临床病例被医学专家评估.
- 电心电图 (ECG) 被用于诊断.
- 应用了纳兰乔药物不良反应概率尺度.
主要成果:
- 患者在输注多克索菲林后出现心和胸部疼痛.
- 电心电图证实了 Paroxysmal 超心室性心动减速.
- 没有发现潜在的心脏,肝脏或脏异常.
- 纳兰乔尺度表明多克索菲林和PSVT之间可能存在关联.
结论:
- 帕洛克斯性脑上性心力衰竭是多克索菲林的一种罕见但可信的不良反应.
- 临床医生应该意识到这种潜在的副作用,并相应地监测患者.
更多相关视频
08:42Cox-Maze IV Procedure Concomitant with Valvular Surgery In Situs Inversus Dextrocardia: A Single-Center Experience in China
Published on: February 11, 2022
09:36Dual-Dye Optical Mapping of Hearts from RyR2R2474S Knock-In Mice of Catecholaminergic Polymorphic Ventricular Tachycardia
Published on: December 22, 2023
相关概念视频
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
Increased pulse rate
Many factors can elevate the risk of developing tachycardia. These include advanced age, a family history of arrhythmias, and an...
Disturbances in Heart Rhythm
Arrhythmias are categorized by their speed, rhythm, and origin. A slow...
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
